US Patent Issued to KYOWA KIRIN on June 3 for "Human monoclonal antibody human CD134 (OX40) and methods of making and using same" (Japanese, American Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,741, issued on June 3, was assigned to KYOWA KIRIN Co. LTD. (Tokyo).

"Human monoclonal antibody human CD134 (OX40) and methods of making and using same" was invented by Shinichiro Kato (Chiba, Japan), Rachel Soloff Nugent (San Diego), Hitoshi Yoshida (Gunma, Japan) and Michael Croft (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides antibodies that specifically bind to OX40 (CD134), referred to as OX40 antibodies, anti-OX40 or anti-OX40 antibodies. Invention antibodies that specifically bind to OX40 include mammalian (human, primate, etc.), humanized and chimeric anti-OX40 antibodies. Invention antibodies and antibody su...